CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,029,401 | +2.3% | 204,664 | +13.2% | 0.18% | +12.5% |
| Q2 2023 | $5,895,347 | -16.0% | 180,728 | -9.4% | 0.16% | -21.2% |
| Q1 2023 | $7,017,449 | +95531.6% | 199,416 | +24.5% | 0.20% | -11.7% |
| Q4 2022 | $7,338 | -99.9% | 160,143 | +7.6% | 0.23% | -1.7% |
| Q3 2022 | $7,211,000 | +5.2% | 148,834 | -14.7% | 0.23% | +13.0% |
| Q2 2022 | $6,856,000 | -15.2% | 174,493 | -20.5% | 0.21% | +8.4% |
| Q1 2022 | $8,081,000 | -18.1% | 219,540 | +1.5% | 0.19% | -3.5% |
| Q4 2021 | $9,863,000 | -4.3% | 216,380 | -25.0% | 0.20% | -7.5% |
| Q3 2021 | $10,311,000 | +22.8% | 288,496 | -32.0% | 0.21% | +41.7% |
| Q2 2021 | $8,394,000 | -19.2% | 424,175 | -5.0% | 0.15% | -21.8% |
| Q1 2021 | $10,387,000 | -10.0% | 446,554 | -19.6% | 0.19% | -12.3% |
| Q4 2020 | $11,547,000 | – | 555,684 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |